Welcome to LookChem.com Sign In|Join Free
  • or
3-{5-[bis(2-chloroethyl)amino]-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}propanoic acid is a complex organic compound with the molecular formula C10H15Cl4N3O4. It is a derivative of pyrimidine, a heterocyclic aromatic organic compound consisting of a six-membered ring with four carbon atoms and two nitrogen atoms. The compound features a propanoic acid group (a three-carbon carboxylic acid chain) attached to a pyrimidinyl moiety, which is further substituted with a bis(2-chloroethyl)amino group at the 5-position. This bis(2-chloroethyl)amino group is a key structural element, as it contains two chlorine atoms attached to an ethylamine chain. The compound's structure and properties make it potentially useful in various chemical and pharmaceutical applications, such as the synthesis of therapeutic agents or as a building block in the creation of more complex molecules.

148-08-3

Post Buying Request

148-08-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

148-08-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 148-08-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,4 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 148-08:
(5*1)+(4*4)+(3*8)+(2*0)+(1*8)=53
53 % 10 = 3
So 148-08-3 is a valid CAS Registry Number.

148-08-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[5-[bis(2-chloroethyl)amino]-2,4-dioxopyrimidin-1-yl]propanoic acid

1.2 Other means of identification

Product number -
Other names 3-{5-[bis-(2-chloro-ethyl)-amino]-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl}-propionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:148-08-3 SDS

148-08-3Downstream Products

148-08-3Relevant academic research and scientific papers

Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A

Baraldi, Pier Giovanni,Romagnoli, Romeo,Guadix, Antonio Entrena,Pineda de las Infantas, Maria Josè,Gallo, Miguel Angel,Espinosa, Antonio,Martinez, Alberto,Bingham, John P.,Hartley, John A.

, p. 3630 - 3638 (2002)

The design, synthesis, characterization, DNA binding properties, and cytotoxic activity of a novel series of hybrids, namely, a molecular combination of the natural antibiotic distamycin A and the antineoplastic agent uramustine, are reported, and the structure-activity relationships are discussed. This homologous series 29-34 consisted of the minor groove binder distamycin A joined to uramustine (uracil mustard) by suitable aliphatic carboxylic acid moieties containing a flexible polymethylene chain that is variable in length [(CH2)n, where n = 1-6). All the hybrid compounds in this series exhibit enhanced activity compared to both distamycin A and uramustine derivatives 22-27 used for conjugation, giving IC50 values in the range 7.26-0.07 μM following a 1 h exposure of human leukemic K562 cells, with maximal activity shown when n = 6. The distance between the uramustine and distamycin frame is crucial for the cytotoxicity, with compounds having linker lengths of four to six being at least 20-fold more cytotoxic than liker lengths one to three. Taq polymerase stop experiments demonstrated selective covalent binding of uramustine-distamycin hybrids to A/T rich DNA sequences, which was again more efficent with compounds 32-34 with a longer linker length. Two consequences can be derived from our study: (a) the distamycin moiety directs binding to the minor groove of A/T rich DNA sequences and, consequently, is responsible for the alkylation regioselectivity found in footprinting studies; (b) the higher flexibility due to a longer linker between the distamycin and uracil moieties allows the formation of complexes with the mustard moiety situated more deeply in the minor groove and, hence, with better alkylating properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 148-08-3